Covered recipient · General Payments record
BRIGITTE JAQUELINE ENGELMANN
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2018–2024
$1,727.29
- Reported across 100 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $518.92 | 26 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $112.34 | 5 |
| Novo Nordisk AS | $108.97 | 6 |
| Amgen Inc. | $67.42 | 4 |
| SANOFI-AVENTIS U.S. LLC | $47.05 | 2 |
| Acerta Pharma LLC | $35.57 | 2 |
| PFIZER INC. | $33.12 | 2 |
| DEXCOM, INC. | $32.42 | 1 |
| Exact Sciences Corporation | $23.27 | 1 |
| Lilly USA, LLC | $22.79 | 1 |
| Merck Sharp & Dohme Corporation | $19.29 | 1 |
| Cranial Technologies, Inc | $16.68 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (26)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $28.68 | 01/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103693626 | CMS |
| ABBVIE INC. | $20.55 | 04/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103693628 | CMS |
| ABBVIE INC. | $27.56 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103693630 | CMS |
| ABBVIE INC. | $22.46 | 06/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103693632 | CMS |
| ABBVIE INC. | $13.09 | 08/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103693634 | CMS |
| Amgen Inc. | $18.95 | 01/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111570179 | CMS |
| Amgen Inc. | $13.85 | 07/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111570181 | CMS |
| Amgen Inc. | $16.57 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117246367 | CMS |
| Amgen Inc. | $18.05 | 11/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111570183 | CMS |
| AstraZeneca Pharmaceuticals LP | $17.56 | 03/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105494155 | CMS |
| AstraZeneca Pharmaceuticals LP | $18.01 | 10/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104686734 | CMS |
| Cranial Technologies, Inc | $16.68 | 11/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1082220758 | CMS |
| Dexcom, Inc. | $32.42 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153288616 | CMS |
| Exact Sciences Corporation | $23.27 | 02/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114469292 | CMS |
| Lilly USA, LLC | $22.79 | 05/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136080043 | CMS |
| Merck Sharp & Dohme LLC | $19.29 | 04/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141907594 | CMS |
| Novo Nordisk Inc | $18.53 | 01/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097450771 | CMS |
| Novo Nordisk Inc | $23.56 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096888362 | CMS |
| Novo Nordisk Inc | $15.24 | 03/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096948342 | CMS |
| Novo Nordisk Inc | $20.60 | 06/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097147778 | CMS |
| Novo Nordisk Inc | $14.93 | 07/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097691275 | CMS |
| Novo Nordisk Inc | $16.11 | 12/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097462424 | CMS |
| PFIZER INC. | $18.79 | 05/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132008786 | CMS |
| PFIZER INC. | $14.33 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131848725 | CMS |
| SANOFI-AVENTIS U.S. LLC | $21.92 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139873669 | CMS |
| SANOFI-AVENTIS U.S. LLC | $25.13 | 10/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139873735 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.